New Year Bumper Sale @ Rs. 1 X
Adcyclo, with the active ingredient Cyclophosphamide, is an alkylating agent used primarily in cancer treatment and as an immunosuppressive drug. It works by damaging DNA in rapidly dividing cells, leading to their death. Cyclophosphamide is highly versatile and is used in oncology and autoimmune disease management.
Uses
Cancers:
Autoimmune diseases:
Cyclophosphamide is a prodrug converted in the liver to its active form. It cross-links DNA strands, inhibiting DNA replication and transcription, leading to cell death, particularly in rapidly dividing cells like cancer and immune cells.
Onset and Duration of Action
Adcyclo is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Adcyclo is used -
Mild
Is the use of Adcyclo safe for pregnant women?
Is the use of Adcyclo safe during breastfeeding?
What is the effect of Adcyclo on the Kidneys?
What is the effect of Adcyclo on the Liver?
What is the effect of Adcyclo on the Heart?
Adcyclo should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Adcyclo unless your doctor advises you to do so -
Is this Adcyclo habit forming or addictive?
Is it safe to drive or operate heavy machinery when consuming?
Is it safe?
Is it able to treat mental disorders?
Interaction between Food and Adcyclo
Interaction between Alcohol and Adcyclo
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cyclophosphamide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 860
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 375-377